ASPI Overview

ASP Isotopes Inc. is a development stage advanced materials company. The Company is engaged in the development of technology and processes to produce isotopes for use in multiple industries. The Company employs proprietary technology, the Aerodynamic Separation Process (ASP technology). Its initial focus is on producing and commercializing highly enriched isotopes for the healthcare and technology industries. Its Nuclear Fuels segment is focused on research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its Specialist Isotopes and Related Services segment is focused on research and development of technologies and methods used to separate high-value, low-volume isotopes (such as C-14, Mo-100, and Si-28) for highly specialized target end markets other than advanced nuclear fuels, including pharmaceuticals and agrochemicals, nuclear medical imaging, and others.

Wall Street analysts forecast ASPI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ASPI is12.00 USD with a low forecast of 11.00 USD and a high forecast of 13.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

ASP Isotopes Inc revenue for the last quarter amounts to 4.89M USD, increased 349.53

ASP Isotopes Inc. EPS for the last quarter amounts to -0.15 USD, increased 25.00

ASP Isotopes Inc (ASPI) has 136 emplpoyees as of March 02 2026.

Today ASPI has the market capitalization of 688.11M USD.